Kenneth T. Mills

Director

Kenneth T. Mills (Director) filed 1 Form 4 report in the past 24 months (0 purchases, 1 sale), most often in REGENXBIO Inc. (RGNX). The largest single filing was $163K of RGNX (20,602 sh × $7.91, as filed), executed May 12 2025.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 1 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$163K

shares × price, as filed

Last traded

May 12 2025

Filed May 14 2025

Median ADV $23.2M across their filed names

Open performance→

Volume by month

Buys $0 Sells $163K

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 1 filing

Sector per market data · by filing · past 24 months

Most traded names

RGNX

REGENXBIO Inc. RGNX · 0 buys · 1 sell 1 filing

Recent filings

RGNXSALE REGENXBIO Inc. View filing → $163K
20,602 sh × $7.91
Exec May 12 2025
Filed May 14 2025 · 5:30 PM ET